The DOI matches its Crossref record; 56 of the 58 references it cites were found in a registry or an index.
Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator
Open accessAbstract
Curcumin is a natural product currently in human clinical trials for a variety of neoplastic, preneoplastic, and inflammatory conditions. We previously observed that, in cultured cells, curcumin exhibits properties of an iron chelator. To test whether the chelator activity of curcumin is sufficient to induce iron deficiency in vivo, mice were placed on diets containing graded concentrations of both iron and curcumin for 26 weeks. Mice receiving the lowest level of dietary iron exhibited borderline iron deficiency, with reductions in spleen and liver iron, but little effect on hemoglobin, hematocrit, transferrin saturation, or plasma iron. Against this backdrop of subclinical iron deficiency, curcumin exerted profound 2 effects on systemic iron, inducing a dose-dependent decline in hematocrit, hemoglobin, serum iron, and transferrin saturation, the appearance of microcytic anisocytotic red blood cells, and decreases in spleen and liver iron content. Curcumin repressed synthesis of hepcidin, a peptide that plays a central role in regulation of systemic iron balance. These results demonstrate that curcumin has the potential to affect systemic iron metabolism, particularly in a setting of subclinical iron deficiency. This may affect the use of curcumin in patients with marginal iron stores or those exhibiting the anemia of cancer and chronic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies with cell and mouse models showed that downstream inhibition of the IL-6/STAT3 signaling pathway by using small molecule inhibitors of STAT3 (curcumin, AG490 and PpYLKTK) likewise decreases hepcidin (Jiao et al., 2009; Fatih et al., 2010; Zhang et al., 2011).”
From Pharmacological Targeting of the Hepcidin/Ferroportin Axis (2016) · cites this paper as Jiao et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650
Curcumin as “Curecumin”: From kitchen to clinic
Goel, A., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.016 · Cited by 2,214
Curcumin: From ancient medicine to current clinical trials
Hatcher, H., Planalp, R., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,843
Self-citationPigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
Aggarwal, B. B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.003 · Cited by 1,574
Dose escalation of a curcuminoid formulation
Lao, C. D., Ruffin, M. T., Normolle, D., Heath, D. D., Murray, S. I., Bailey, J. M., Boggs, M. E., Crowell, J., Rock, C. L., & Brenner, D. E. (2006) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-6-10 · Cited by 1,394
Ammon, H., & Wahl, M. (1991) · Planta Medica · doi:10.1055/s-2006-960004 · Cited by 1,347
Regulation of ferritin genes and protein
Torti, F. M., & Torti, S. V. (2002) · Blood · doi:10.1182/blood.v99.10.3505 · Cited by 1,173
Self-citationThe role of iron regulatory proteins in mammalian iron homeostasis and disease
Rouault, T. A. (2006) · Nature Chemical Biology · doi:10.1038/nchembio807 · Cited by 1,055
Research works printed but not linked: 1
- Vaage, 1994, Chemoprevention and therapy of mouse mammary carcinomas with doxorubicin encapsulated in sterically stabilized liposomes., Cancer, 73, 2366, 10.1002/1097-0142(19940501)73:9<2366::aid-cncr2820730920>3.0.co;2-6 · doi:10.1002/1097-0142(19940501)73:9<2366::aid-cncr2820730920>3.0.co;2-6
Cited by
Iron and cancer: more ore to be mined
Torti, S. V., & Torti, F. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3495 · Cited by 1,621
Self-citationCurcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
Bar-Sela, G., Epelbaum, R., & Schaffer, M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790149738 · Cited by 479
“[39] observed that, in cultured cells, curcumin exhibits properties of an iron chelator.”
BackgroundDegradation of Curcumin: From Mechanism to Biological Implications
Schneider, C., Gordon, O. N., Edwards, R. L., & Luis, P. B. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b00244 · Cited by 442
Curcumin, a component of turmeric: From farm to pharmacy
Gupta, S. C., Kismali, G., & Aggarwal, B. B. (2013) · BioFactors · doi:10.1002/biof.1079 · Cited by 396
“Third, curcumin was recently found to be an active iron chelator and to induce anemia in mice fed iron-poor diets [125].”
BackgroundKell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“…and Harikumar 2009; Aggarwal and Sung 2009; Anand et al. 2010; Basile et al. 2009; Epstein et al. 2009; Hegde et al. 2009; Iqbal et al. 2009; Jiao et al. 2009; Jurenka 2009; Kalpravidh et al. 2010; Majumdar et al. 2009; Messner et al. 2009; Patil et al. 2009; Ravindran et al. 2009;…”
Background
Metadata
- Authors
- Jiao, Y., Wilkinson, J., Di, X., Wang, W., Hatcher, H., Kock, N. D., D'Agostino, R., Knovich, M. A., Torti, F. M., & Torti, S. V.
- Affiliations
- Department of Cancer Biology,
- Department of Pathology,
- Comprehensive Cancer Center,
- Section of Hematology/Oncology, and
- Wake Forest University Health Sciences (US)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2009-01-08
- Volume
- 113
- Issue
- 2
- Pages
- 462-469
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC2615657
- OpenAlex
- W2021711019
- Cited by
- 266
- References
- 58
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 8 · 2023: 20 · 2022: 14 · 2021: 25 · 2020: 17 · 2019: 10 · 2018: 16 · 2017: 18 · 2016: 21 · 2015: 27 · 2014: 13 · 2013: 15 · 2012: 9
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Institute for Cancer Research
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R37 DK42412, KO1 DK065876, K01DK065876, R37DK042412)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- curcumin, iron chelation, subclinical iron deficiency, hepcidin, anemia of chronic disease, cancer-related anemia, dietary iron, chemoprevention
- MeSH terms
- Animals, Antineoplastic Agents, Curcumin, Food, Formulated, Hematocrit, Hemoglobins, Humans, Iron Chelating Agents, Liver, Mice, Inbred C3H, Neoplasms, Spleen, Transferrin, Iron, Dietary, Antimicrobial Cationic Peptides, Mice, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. https://app.cochat.ai/papers/10.1182/blood-2008-05-155952
- The paper
- Jiao, Y., Wilkinson, J., Di, X., Wang, W., Hatcher, H., Kock, N. D., D'Agostino, R., Knovich, M. A., Torti, F. M., & Torti, S. V. (2009). Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. Blood. https://doi.org/10.1182/blood-2008-05-155952
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.